Aktienanalyse zu IB Acquisition Corp (IBAC)

KI-Analyse of IB Acquisition Corp (IBAC)

Verkaufen

IB Acquisition Corp is not a good buy right now due to significant financial struggles and negative momentum. The current price is $10.81, with a 52-week high of $11.64, indicating it is near the lower end of its range. The RSI is at 20.283, which suggests it is oversold, but this could indicate a continued downward trend rather than a buying opportunity. Additionally, the company has reported negative net income in the last three quarters, with a loss of $639,866 in Q2 2026, raising concerns about its financial health.

Bewertungskennzahlen

Das aktuelle erwartete KGV von IB Acquisition Corp (IBAC) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet

5J-Durchschnitt P/E

0.00

Aktuelles P/E

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes EV/EBITDA

Stark unterbewertet

5J-Durchschnitt EV/EBITDA

0.00

Aktuelles EV/EBITDA

0.00

Überbewertet

0.00

Unterbewertet

0.00

Erwartetes KUV

Fair bewertet

5J-Durchschnitt P/S

0.06

Aktuelles P/S

0.00

Überbewertet

0.83

Unterbewertet

-0.72

Alphio-AI-Kursszenarien für IBAC

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%IBAC

$11.75

Szenariopreis

B

Basis

Basis · 50%IBAC

$10.62

Szenariopreis

B

Bärisch

Bärisch · 25%IBAC

$10.48

Szenariopreis

IBAC FAQ – beantwortet von Alphio AI

IB Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the Business Combination). It intends to focus on pursuing an acquisition of or merger with high-growth companies in a number of industries including but not limited to fintech, healthcare and life sciences, sports and entertainment, and consumer goods. The Company anticipates targeting companies domiciled in North America, Europe and Asia, with an enterprise value of at least $500 million. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

IB Acquisition Corp is not a good buy right now due to significant financial struggles and negative momentum. The current price is $10.81, with a 52-week high of $11.64, indicating it is near the lower end of its range. The RSI is at 20.283, which suggests it is oversold, but this could indicate a continued downward trend rather than a buying opportunity. Additionally, the company has reported negative net income in the last three quarters, with a loss of $639,866 in Q2 2026, raising concerns about its financial health.